Bank of New York Mellon Corp - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 115 filers reported holding DENALI THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$40,510,884
-31.0%
1,963,688
-1.3%
0.01%
-25.0%
Q2 2023$58,716,261
+26.4%
1,989,707
-1.3%
0.01%
+20.0%
Q1 2023$46,462,991
-16.7%
2,016,623
+0.5%
0.01%
-23.1%
Q4 2022$55,784,634
-4.1%
2,005,920
+5.8%
0.01%
-7.1%
Q3 2022$58,167,000
+5.8%
1,895,292
+1.5%
0.01%
+7.7%
Q2 2022$54,978,000
+6.2%
1,868,130
+16.1%
0.01%
+30.0%
Q1 2022$51,769,000
+24.5%
1,609,217
+72.6%
0.01%
+25.0%
Q4 2021$41,594,000
+118.9%
932,592
+147.6%
0.01%
+100.0%
Q3 2021$19,005,000
-30.3%
376,719
+8.4%
0.00%
-20.0%
Q2 2021$27,248,000
+82.6%
347,369
+32.9%
0.01%
+66.7%
Q1 2021$14,924,000
-59.4%
261,364
-40.5%
0.00%
-62.5%
Q4 2020$36,802,000
+41.1%
439,370
-39.7%
0.01%
+33.3%
Q3 2020$26,091,000
+67.0%
728,209
+12.7%
0.01%
+50.0%
Q2 2020$15,619,000
+159.5%
645,962
+87.9%
0.00%
+100.0%
Q1 2020$6,020,000
+2.8%
343,747
+2.2%
0.00%0.0%
Q4 2019$5,857,000
+12.8%
336,230
-0.8%
0.00%
+100.0%
Q3 2019$5,192,000
+10.2%
338,917
+49.3%
0.00%0.0%
Q2 2019$4,713,000
-11.1%
227,020
-0.5%
0.00%0.0%
Q1 2019$5,299,000
+12.7%
228,174
+0.3%
0.00%0.0%
Q4 2018$4,700,000
+6.1%
227,505
+11.7%
0.00%0.0%
Q3 2018$4,428,000
+374.6%
203,696
+232.9%
0.00%
Q2 2018$933,000
-9.4%
61,196
+17.0%
0.00%
Q1 2018$1,030,00052,3140.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$298,165,00048.02%
Bratton Capital Management, L.P. 953,035$14,600,00028.53%
Flagship Pioneering Inc. 8,005,747$122,648,0006.71%
Casdin Capital, LLC 650,000$9,958,000,0001.03%
Temasek Holdings (Private) Ltd 4,410,457$67,568,0000.50%
MARK ASSET MANAGEMENT LP 68,864$1,055,0000.26%
IRONWOOD INVESTMENT MANAGEMENT LLC 22,507$345,0000.26%
Artal Group S.A. 400,000$6,128,0000.25%
PIER 88 INVESTMENT PARTNERS LLC 40,610$622,0000.24%
HAMILTON LANE ADVISORS LLC 30,948$474,0000.20%
View complete list of DENALI THERAPEUTICS INC shareholders